EFG Asset Management (Americas)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-48,804
| Closed | -$1.89M | – | 131 |
|
|
2022
Q1 | $1.89M | Buy |
48,804
+2,244
| +5% | +$87K | 0.35% | 70 |
|
|
2021
Q4 | $2.72M | Buy |
46,560
+7,291
| +19% | +$427K | 0.46% | 66 |
|
|
2021
Q3 | $2.33M | Buy |
39,269
+466
| +1% | +$27.6K | 0.41% | 71 |
|
|
2021
Q2 | $3.37M | Buy |
38,803
+4,540
| +13% | +$394K | 0.63% | 58 |
|
|
2021
Q1 | $2.83M | Buy |
+34,263
| New | +$2.83M | 0.58% | 64 |
|